- In June 2024, Lumenis Be. Ltd. launched FoLix, an FDA-approved laser system designed to treat hair loss. As the first fractional laser system of its kind available in the U.S., FoLix offers an effective and natural solution for hair restoration for both men and women
- In May 2024, Sinclair introduced Sculpt & Shape, a new energy-based device (EBD) technology focused on body contouring and facial rejuvenation, showcasing Sinclair's commitment to advancing aesthetic treatment options
- In April 2024, Venus Concept Inc. received approval from Australia's Therapeutic Goods Administration (TGA) for its Venus Versa Pro system. The device combines features from the Venus Viva MD applicator and Venus Versa system, reinforcing Venus Concept’s role as a leader in medical aesthetic innovation
- In February 2024, Cynosure and Hahn & Company, the acquirer of Lutronic, finalized a merger agreement to strategically combine the two companies. This union brings together two leading providers of energy-based medical aesthetic treatment systems, expanding their global reach
- In January 2024, following its acquisition of Lutronic, Cynosure and Hahn & Company announced a definitive merger agreement to strategically merge Cynosure and Lutronic. This merger is expected to create a prominent player in medical aesthetics, with a diverse and innovative product line-up available across over 130 countries
